Abstract
The study shows for the first time the presence of the Klebsiella oxytoca strain fp10 coproducing plasmid-mediated KPC-2 and IMP-8 carbapenemases. The strain was obtained from the fecal sample of an inpatient and showed high-level resistance to imipenem and ertapenem (MICs > 32 μg/ml). Conjugation experiments demonstrated the transferability of the carbapenem-resistant determinants. The results of plasmid analysis and Southern hybridization revealed that the blaKPC-2 gene was located on transferable plasmid pFP10-1 (∼54 kb), whereas the blaIMP-8 gene was on transferable plasmid pFP10-2 (∼180 kb). Analysis of the genetic environment of these two genes has demonstrated that ISKpn6 and ISKpn8 are involved in the spread of the blaKPC-2 gene, while the transposable elements IS26, intI1, and tniC might contribute to the dissemination of the blaIMP-8 gene. The chimera of several transposon-associated elements indicated a novel genetic environment of IMP-type metallo-β-lactamase gene in Enterobacteriaceae from China.
INTRODUCTION
The carbapenems, such as imipenem and meropenem, are used widely during the treatment of serious infections caused by multiresistant Gram-negative bacteria, especially strains producing high levels of AmpC cephalosporinases or extended-spectrum β-lactamase (ESBLs). Recently, however, carbapenem resistance has increasingly reported in Enterobacteriaceae, and the carbapenem resistance can mostly be mediated by carbapenem-hydrolyzing enzymes, such as metallo-β-lactamases (MBLs) and Klebsiella pneumoniae carbapenemases (KPCs) (12, 18). The emergence and spread of carbapenemases has caused problems regarding therapy and control.
Carbapenem-hydrolyzing KPC β-lactamases are classified into subgroup 2f serine β-lactamases, which are capable of hydrolyzing carbapenems, penicillins, cephalosporins, and aztreonam. These enzymes can be inhibited by clavulanic acid and tazobactam (2). KPCs in particular have recently been associated with major outbreaks of multidrug-resistant Gram-negative bacterial infections (2). KPC-producing bacteria were first reported in North Carolina (29). blaKPC is now present among Enterobacteriaceae isolates worldwide (12, 18) and can even be detected among nonfermentative bacilli, such as Pseudomonas aeruginosa and Acinetobacter species (16, 19, 26). The dissemination of KPC producers poses a serious threat to public health.
MBLs belong to functional subgroup 3a β-lactamases, which can hydrolyze all β-lactam antibiotics except monobactams (2) and are not inhibited by β-lactamases inhibitors. However, the activity of these enzymes can be inhibited by metal ion chelators such as EDTA (2). MBLs, especially IMP and VIM, have emerged in multiple species and recently disseminated into several members of the Enterobacteriaceae family (1, 5, 8). In China, there have been several reports of IMP in Enterobacteriaceae (3, 6, 10). However, there has been no report of coproduced KPC and IMP carbapenemases in Enterobacteriaceae thus far in the world. In the present study, we describe a commensal carbapenem-resistant Klebsiella oxytoca strain that produces both KPC-2- and IMP-8-type carbapenemases, and we characterize the genetic environment of both resistance genes. This is the first report, to our knowledge, of detection of the plasmid-mediated carbapenem-hydrolyzing KPC-2 and IMP-8 simultaneously in one Enterobacteriaceae.
MATERIALS AND METHODS
Bacterial strain.
During January to May 2009, an investigation was carried out in one region of China to study the prevalence of fecal carriage with ESBL-producing Enterobacteriaceae in healthy persons and inpatients. All of the fecal samples were seeded onto MacConkey agar plates, which were supplemented with 1 μg of cefotaxime/ml. Also, one ESBL-producing K. oxytoca strain (fp10) was isolated from the fecal sample of a randomly selected patient, who was a 5-year-old patient hospitalized in the pediatric ward in the Union Hospital of Fujian Medical University. The strain showed resistant to imipenem and ertapenem. The patient suffered from acute leukemia and had some clinical infections, including bacteremia and perianal abscess. During his hospitalization, imipenem was repeatedly administered. Identification of the strain was determined by using the Vitek system.
Antimicrobial susceptibility testing and phenotypic screening.
The MICs of imipenem, ertapenem, cefepime, ceftazidime, cefotaxime, ceftriaxone, cefoxitin, aztreonam, cefoperazone-sulbactam, piperacillin-tazobactam, ciprofloxacin, gentamicin, and amikacin were determined on strain fp10 by the Etest technique (AB Biodisk, Sweden). Antibiotic susceptibility testing of ertapenem and aztreonam was performed on the transconjugant strains by the disc diffusion method. The susceptibility breakpoints were interpreted as recommended by the Clinical and Laboratory Standards Institute (4). Escherichia coli ATCC 25922 was used as a quality control. A phenotypic detection method using combined disc tests of meropenem alone and with phenylboronic acid (PBA) or EDTA or both PBA and EDTA was evaluated for the detection of carbapenemase (25).
PCR detection and DNA sequencing.
Plasmid DNAs isolated from K. oxytoca fp10 and E. coli transconjugant were obtained by the alkaline lysis method (20) and were used as a template in PCR analyses with primers that are specific for blaKPC, blaIMP, blaVIM, and OXA-type carbapenemases as described previously (14, 15, 23). The blaTEM, blaSHV, blaCTX-M, and plasmidic AmpC genes were also amplified by PCR (13, 28). The PCR products were purified and sequenced twice on both strands by Invitrogen (Invitrogen, Shanghai).
Conjugation experiment and plasmid analysis.
Conjugation transfer assay was performed in broth culture with E. coli J53 Azr as the recipient (28). Donor and recipient cells were mixed at a ratio of 1:1. Transconjugants were selected on MacConkey agar containing ampicillin (100 mg/liter) supplemented with sodium azide (100 mg/liter; Sigma Chemical Co.). The colonies grown on the selecting medium were selected and identified by the Vitek system. Plasmid DNA was isolated by alkaline lysis method and examined by agarose gel electrophoresis. The plasmid sizes were estimated by comparison to the plasmids from E. coli V517 (54.2, 7.3, 5.6, 5.2, 3.9, 3.1, 2.7, and 2.1 kb) (9) and E. coli R27 (182 kb) (24) as the standard markers. Primers targeting blaKPC and blaIMP genes were as described previously.
Southern hybridization.
Plasmid DNA was extracted by alkaline lysis method (20). Purified plasmids were electrophoresed in a 1.0% agarose gel and transferred to a positively charged nylon membrane (Roche Applied Science, Mannheim, Germany). The membrane was probed with PCR-amplified KPC-2 and IMP-8 gene probes, respectively. The probes were prepared by using a DIG High-Prime DNA labeling and detection kit (Roche Applied Science).
Genetic environment of carbapenem-resistant determinants.
The genetic organization of carbapenem-resistant determinants was investigated by gene cloning with plasmid DNA digested and ligated in the EcoRI and BamHI sites of the pACYC 184 vector (28). All enzymes for DNA manipulations were used according to the recommendations of the supplier (Amersham Biosciences). Recombinant plasmids were transformed into E. coli DH5α. The transformants harboring the recombinant KPC- or IMP-encoding plasmids were selected on LB agar plates supplemented with ampicillin (100 mg/liter). The molecular sizes of the inserts were estimated from the results of restriction digestion and electrophoresis in 1% agarose gel in TAE buffer. Finally, inserted fragments were sequenced on both strands on an ABI Prism 3730XL DNA analyzer (Applied Biosystems).
Nucleotide sequence accession numbers.
The nucleotide sequences reported here have been assigned to the EMBL/GenBank nucleotide database under the accession numbers HQ651092 and HQ651093.
RESULTS
Antimicrobial susceptibility testing and phenotypic screening.
The MICs of a variety of antimicrobial agents against strain fp10 are shown in Table 1. The results showed that fp10 strain was a multidrug-resistant isolate, and it also exhibited high-level resistance to imipenem and ertapenem (MICs ≥ 32 μg/ml). Of note, the strain was only susceptible to ciprofloxacin (MIC = 0.75 μg/ml). The zone diameters of meropenem alone, with PBA or EDTA, or with both PBA and EDTA were 6, 6,10, and 16 mm, respectively. The simultaneous presence of both MBLs and KPCs was indicated by a ≥5-mm increase in the zone diameter of the combined disc test using meropenem with or without both PBA and EDTA.
Table 1.
MICs of antibiotics for K. oxytoca fp10, various E. coli transconjugants, E. coli DH5α, and the E. coli J53 clone
Antimicrobial agent | MIC (μg/ml) for: |
||||||
---|---|---|---|---|---|---|---|
K. oxytoca fp10 | E. coli DH5α (pACYC184-blaKPC-2) | E. coli DH5α (pACYC184-blaIMP-8) | E. coli J53 (blaKPC-2 + blaIMP-8) | E. coli J53 (blaIMP-8) | E. coli DH5α | E. coli J53 | |
Imipenem | >32 | 32 | 8 | >32 | >32 | 0.19 | 0.19 |
Ertapenem | >32 | 16 | 1.5 | >32 | >32 | 0.006 | 0.016 |
Cefepime | >256 | 1 | 6 | 128 | 16 | 0.032 | 0.016 |
Cefotaxime | >256 | 6 | 6 | 128 | 32 | 0.032 | 0.016 |
Ceftazidime | >256 | 6 | 12 | >256 | 32 | 0.064 | 0.016 |
Ceftriaxone | >256 | 16 | 12 | 128 | 16 | 0.032 | 0.023 |
Cefoxitin | >256 | 24 | 24 | 64 | 24 | 0.032 | 0.016 |
Piperacillin-tazobactam | >256 | 32 | 12 | 128 | 32 | 0.032 | 0.032 |
Cefoperazone-sulbactam | >256 | 24 | 16 | 256 | 16 | 0.032 | 0.016 |
Aztreonam | >256 | 24 | 0.064 | 64 | 0.064 | 0.016 | 0.032 |
Gentamicin | >256 | 0.5 | 0.25 | >256 | >256 | 0.094 | 0.125 |
Amikacin | >256 | 0.75 | 1.5 | >256 | >256 | 0.75 | 0.75 |
Ciprofloxacin | 0.75 | <0.002 | <0.002 | 0.032 | 0.006 | 0.008 | 0.006 |
PCR detection and DNA sequencing.
PCR showed that strain fp10 was positive for blaTEM, blaKPC, and blaIMP genes and negative for the remaining genes tested, including all blaSHV and blaCTX-M variants. Sequencing analysis identified blaTEM-1, blaKPC-2, and blaIMP-8 alleles.
Conjugation experiment and plasmid analysis.
Plasmid in strain fp10 successfully transferred carbapenem resistance into E. coli J53 by conjugation. Transconjugants exhibited a phenotype of resistance or reduced susceptibility to ertapenem. Phenotypic testing of many transconjugant colonies showed that there was some different resistance to aztreonam. PCR assays showed that all aztreonam-resistant transconjugant colonies tested were positive for blaKPC-2 and blaIMP-8 genes, while the remaining aztreonam-susceptibility colonies tested were positive for blaIMP-8 gene. The plasmid analysis of the parental isolate showed that the strain harbored four plasmids of ca. 3.8, 4.1, 54,and 180 kb (data not shown). The transconjugants bearing blaKPC and blaIMP had two plasmids of ∼54 (pFP10-1) and ∼180 kb (pFP10-2), while transconjugants bearing blaIMP but not blaKPC had a single plasmid of ∼180 kb (pFP10-2). PCR analysis, using as a template the gel-extracted plasmid DNA band of the transconjugants, confirmed the carriage of the blaKPC gene on the plasmid pFP10-1, and the blaIMP gene was on plasmid pFP10-2. Hybridization analysis with the probe specific for the blaKPC-2 and blaIMP-8 genes revealed that blaKPC-2 was located on the plasmid of ∼54 kb, while blaIMP-8 gene was on the ∼180-kb plasmid (Fig. 1). Repeated mating experiments were carried out but failed to isolate any transconjugants with a single plasmid pFP10-1. Electrophoretic profiles of K. oxytoca strain fp10 and hybridization analysis results are shown in Fig. 1. The MICs for the transconjugant colonies (i.e., either bearing both blaKPC and blaIMP or bearing blaIMP but not blaKPC) of the antibiotics are given in Table 1.
Fig. 1.
Electrophoretic profiles of plasmids (A) and hybridization with a blaKPC-2-specific (B) or a blaIMP-8-specific (C) probe. Lanes 1, 6, and 11, λ-HindIII-digested DNA (New England Biolabs, Beverly, MA); lanes 5, 10, and 15, marker (E. coli V517); lane 2, transconjugant harboring plasmid pFP10-2; lane 3, transconjugant harboring plasmids pFP10-1 and pFP10-2; lane 4, K. oxytoca strain fp10.
Characterization of the genetic environment of the blaKPC-2 and blaIMP-8 genes.
For the blaKPC-2 gene, cloning isolates were found to have recombinant plasmids carrying a 6,964-bp inserted fragment. The nucleotide sequence of the inserted fragment was determined and revealed several open reading frames (ORFs) (Fig. 2). Upstream of the blaKPC-2 gene was located a putative ISKpn8 element, and a truncated blaTEM gene was inserted between them. An ISKpn6-like element was located downstream of the carbapenemase gene, followed by the pKP048-08, the klcA, the pKP048-09, and the korC genes. pKP048-08 and pKP048-09 genes encode hypothetical proteins. The klcA gene encodes the antirestriction protein KlcA, while the korC gene encodes the transcriptional repressor protein KorC. All four of these genes shared 100% nucleotide identity with the corresponding sequence on plasmid pKP048 (GenBank accession no. FJ628167).
Fig. 2.
(a) Schematic representation of the genetic structure involved in the blaIMP-8 gene in plasmid pFP10-2. (b) Schematic representation of the genetic environment of the blaKPC-2 gene in plasmid pFP10-1 compared to that found around the blaKPC-2 gene in plasmid pKP048. The diagram of pKP048 is drawn based on the nucleotide sequences available in GenBank under accession number FJ628167.
For blaIMP-8, a nucleotide sequence of 5,201 bp surrounding the gene was obtained. The annotation of this sequence revealed several ORFs, and some of these have been associated with the blaIMP-8 gene (Fig. 2). The blaIMP-8 genes cassette is located downstream of the attI1 recombination site, followed by an aacA4 cassette and a tniC gene cassette. TniC is a putative resolvase, which involves in transposition. Upstream of the blaIMP-8 gene are located a class 1 integron, orf44, and one short gene fragment. The orf44 gene shares 100% identical to the corresponding sequence on plasmid pCTX-M3 (GenBank accession no. AF550415) and encodes the hypothetical protein Orf44. One replication initiator protein is encoded by the short gene fragment, which shares 99% nucleotide identity with the Rep_3 gene on plasmid pKPN5 (GenBank accession no. CP000650). However, the intI1 gene in the 5′-conserved region is disrupted and flanked by a putative IS26 insertion.
DISCUSSION
In 2009, 0.4% of Enterobacteriaceae isolates showed resistance to imipenem in the hospital where this study was conducted. Among the nonfermentative bacteria, the resistances of P. aeruginosa and Acinetobacter baumannii to imipenem were 19.8 and 17.9%, respectively (data not published). The data suggested that carbapenem resistance in Enterobacteriaceae isolates emerged in the area, while the carbapenem resistance status in P. aeruginosa and A. baumannii to imipenem remained at a high level. However, no molecular epidemiological data are available on the carbapenemase-producing Gram-negative bacteria in this hospital up to now. In the present study, we reported a fecal K. oxytoca strain that coproduced blaKPC-2 and blaIMP-8. The strain was highly resistant to many antibiotics, including imipenem and ertapenem. Interestingly, the strain was only susceptible to ciprofloxacin. Conjugation assay and Southern hybridization results showed that both of these two resistance genes were located on different transferable plasmids. In addition, the results of the conjugation assay in the present study demonstrated that plasmid pFP10-1 could not transfer from parental strain to the recipient strain without plasmid pFP10-2. Further experiments are needed to investigate the relationship between these two plasmids.
In recent years, many reports have described the presence of KPC β-lactamases (especially KPC-2) in strains of the family Enterobacteriaceae with carbapenem resistance or reduced carbapenem susceptibility from different areas in China (10, 12, 18). It seems that KPC enzymes are becoming widely disseminated in this region, and plasmids of different sizes could harbor the blaKPC-2 gene in China (22).
The genetic environments of the blaKPC gene were characterized in some studies, and various transposon elements seem to be responsible for the rapid spread of blaKPC (11, 22, 28). Tn4401 was considered to be at the origin of blaKPC-like gene acquisition and dissemination (11), while Shen et al. revealed a distinct genetic environment with the chimera of several transposon-associated elements in China, such as Tn3, ISKpn8, and an ISKpn6-like element on plasmid pKP048 (22). In the present study, the genetic environment of the blaKPC-2 gene from a fecal strain showed a structure and context similar to those found in plasmid pKP048, except that a truncated blaTEM gene was inserted and located between ISKpn8 and the blaKPC-2 gene (Fig. 2b). Of note, the similar gene structure (ISKpn8, blaKPC-like gene, and ISKpn6-like element) found in different plasmids in China probably suggests a common origin in this region. The results found in these studies imply that the diversity of genetic environment harboring blaKPC-2 contributes to the wide dissemination of this carbapenem-hydrolyzing β-lactamase in China.
Several studies have shown that blaIMP has emerged in some members of the Enterobacteriaceae in China (3, 6, 10). However, the genetic elements around this MBL gene are still unclear in this region. Most of the IMP-type MBLs are commonly located in class 1 integrons with a site-specific recombination site (attI), which is able to capture genes (18, 27). The blaIMP genes inserted into class 1 integrons might be transferable horizontally because some of them are found on self-transmissible plasmids. However, in the present study, the genetic environment of the blaIMP-8 gene is different. The blaIMP-8 gene is located immediately downstream of the intI1 gene, which is disrupted by IS26 and results in the formation of a composite transposon. This structure is similar to that found in P. aeruginosa (7). As described before, this novel element may facilitate IS26-mediated mobilization of the blaIMP gene (7).
It is also interesting that the tniC gene is located downstream of blaIMP-8. The product of the gene is a resolvase, TniC, which is involved in transposition and plays an important role in spreading MBL genes (21). It seems that the cooperative action of several transposon elements contributes to the dissemination of blaIMP gene among different species of Enterobacteriaceae. Moreover, it is worth noting that blaVIM genes, along with the blaKPC-2 gene, have emerged in K. pneumoniae (17, 30).
In conclusion, our study has demonstrated for the first time the coproduction of plasmid-mediated blaKPC-2 and blaIMP-8 genes in a K. oxytoca strain, and the genetic elements contributing to the dissemination of the two resistance genes were also characterized. The prevalence of the Enterobacteriaceae strains coproducing blaKPC-2 and blaIMP-8 may have serious consequences for clinical therapy, and we suggest that an effective surveillance and strict infection control strategies should be implemented soon to prevent potential outbreaks of nosocomial infections by such pathogens in China.
ACKNOWLEDGMENTS
We thank Zhu Demei, Xu Xiaogang, and Hu Fupin, Institute of Antibiotics, Huashan Hospital, for helpful suggestions in performing the cloning experiment.
Footnotes
Published ahead of print on 21 March 2011.
REFERENCES
- 1. Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558–564 [DOI] [PubMed] [Google Scholar]
- 2. Bush K., Jacoby G. A. 2010. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54:969–976 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Chen L. R., Zhou H. W., Cai J. C., Zhang R., Chen G. X. 2009. Combination of IMP-4 metallo-β-lactamase production and prion deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. Diagn. Microbiol. Infect. Dis. 65:163–167 [DOI] [PubMed] [Google Scholar]
- 4. Clinical and Laboratory Standards Institute 2010. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Approved standard M100–S20. Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]
- 5. Deshpande L. M., Jones R. N., Fritsche T. R., Sader H. S. 2006. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb. Drug Resist. 12:223–230 [DOI] [PubMed] [Google Scholar]
- 6. Hawkey P. M., Xiong J., Ye H., Li H., Mzali F. H. 2001. Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol. Lett. 194:53–57 [DOI] [PubMed] [Google Scholar]
- 7. Kouda S., et al. 2009. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J. Antimicrob. Chemother. 64:46–51 [DOI] [PubMed] [Google Scholar]
- 8. Liu Y. F., Yan J. J., Ko W. C., Tsai S. H., Wu J. J. 2008. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 61:1020–1023 [DOI] [PubMed] [Google Scholar]
- 9. Macrina F. L., Kopecko D. J., Jones K. R., Ayers D. J., McCowen S. M. 1978. A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1:417–420 [DOI] [PubMed] [Google Scholar]
- 10. Mendes R. E., et al. 2008. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene. Antimicrob. Agents Chemother. 52:798–799 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Naas T., Nordmann P., Vedel G., Poyart C. 2005. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob. Agents Chemother. 49:4423–4424 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Nordmann P., Cuzon G., Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228–236 [DOI] [PubMed] [Google Scholar]
- 13. Pérez-Pérez F. J., Hanson N. D. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153–2162 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Pitout J. D., et al. 2005. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129–3135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Poirel L., Héritier C., Tolun V., Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15–22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Poirel L., Nordmann P., Lagrutta E., Cleary T., Munoz-Price L. S. 2010. Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob. Agents Chemother. 54:3072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Pournaras S., et al. 2010. Detection of the new metallo-beta-lactamase VIM-19, along with KPC-2, CMY-2, and CTX-M-15 in Klebsiella pneumoniae. J. Antimicrob. Chemother. 65:1604–1607 [DOI] [PubMed] [Google Scholar]
- 18. Queenan A. M., Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440–448 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Robledo I. E., et al. 2010. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob. Agents Chemother. 54:1354–1357 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Sambrook J., Russell D. W. 2001. Molecular cloning: a laboratory manual, 3rd ed Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY [Google Scholar]
- 21. Samuelsen O., et al. 2009. The first metallo-beta-lactamase identified in Norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrob. Agents Chemother. 53:331–332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Shen P., et al. 2009. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother. 53:4333–4338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Smith-Moland E., et al. 2003. Plasmid-mediated, carbapenem-hydrolyzing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711–714 [DOI] [PubMed] [Google Scholar]
- 24. Taylor D. 1989. General properties of resistance plasmids, p. 325–357 In Bryan L. E. (ed.), Microbial resistance to drugs. Springer-Verlag, Berlin, Germany [Google Scholar]
- 25. Tsakris A., et al. 2010. A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J. Antimicrob. Chemother. 65:1664–1671 [DOI] [PubMed] [Google Scholar]
- 26. Villegas M. V., et al. 2007. The Colombian Nosocomial Resistance Study Group. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553–1555 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Walsh T. R., Toleman M. A., Poirel L., Nordmann P. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306–325 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Wu Q., Zhang Y. B., Han L. Z., Sun J. Y., Ni Y. X. 2009. Plasmid-mediated 16S rRNA methylases in aminoglycoside-resistant Enterobacteriaceae isolates in Shanghai, China. Antimicrob. Agents Chemother. 53:271–272 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Yigit H., et al. 2001. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151–1161 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Zioga A., et al. 2010. The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. Int. J. Antimicrob. Agents 36:190–191 [DOI] [PubMed] [Google Scholar]